Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. NJ BioHistory (TM)
Career
Job Search Post a Job Destination NJ
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad:  Every Child Deserves a Chance to Play Baseball
Advertising
 
Facilities
 

Conference on Biosimilars, University of Washington, Seattle - March 19-20. Sign up today!

Life Science Transportation Awareness Seminars from QuickSTAT. NC, MA, NJ - Register NOW!



BioHistory Moment: Diamond v. Chakrabarty case argued before U.S. Supreme Court

Patent image

On March 17, 1980, the Diamond v. Chakrabarty case was argued before the U.S. Supreme Court regarding the patentability of genetically altered microorganisms.

In 1972, Chakrabarty filed a patent application assigned to the General Electric Co. for a human-made genetically engineered bacterium capable of breaking down multiple components of crude oil. The application asserted 36 claims related to Chakrabarty's invention of a bacterium from the genus Pseudomonas containing at least two stable energy-generating plasmids, each of said plasmids providing a separate hydrocarbon degradative pathway.

On June 16, 1980, the U.S. Supreme Court upheld five-to-four the patentability of genetically altered organisms, opening the door to greater patent protection for any modified life forms. Chief Justice Warren Burger delivered the opinion of the Court, in which justices Potter Stewart, Harry Blackmun, William Rehnquist, and John Paul Stevens joined. William Brennan filed the dissenting opinion, in which Byron White, Thurgood Marshall, and Lewis Powell joined.

More...

Learn about Seattle's Life Science Incubator Facility

PNDRI Building, First Hill, Seattle, WA. Seattle's Life Science Incubator Research facility was commissioned in 1988, and is a contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical space and management offices. The faciility is centrally located in close proximity to downtown Seattle, the University of Washington, the Fred Hutchinson Cancer Research Center, and more.

Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in New Jersey, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • NIH announces genetic testing registry  The National Institutes of Health announced that it is creating a public database that researchers, consumers, health care providers, and others can search for information submitted voluntarily by genetic test providers.
    National Institutes of Health  March 18, 2010  


  • Jury rules in favour of AstraZeneca in first US Seroquel product liability trial  AstraZeneca announced that a jury in a New Jersey state court in the US ruled in favour of AstraZeneca by rejecting a Louisiana plaintiff's claims that SEROQUEL caused his alleged injuries. The case, Baker v. AstraZeneca, was the first product liability case to go to trial.
    AstraZeneca  March 18, 2010  


  • ZIOPHARM reports fourth quarter and full year 2009 financial results  The Company reported net income of $1.0 million, or $0.03 per share for the quarter ended December 31, 2009, compared to a net loss of 4.6 million, or $(0.21) per share, in the fourth quarter of 2008.
    ZIOPHARM Oncology, Inc.  March 18, 2010  


  • FDA approves Envoy Medical 's first totally implanted hearing system   The FDA announced the approval of the Esteem – an implanted hearing system used to treat moderate to severe sensorineural hearing loss, a type of permanent hearing loss. As a condition of FDA approval, Esteem manufacturer, Envoy Medical of St. Paul, Minn., must conduct two post-approval studies.
    U.S. Food and Drug Administration  March 18, 2010  


  • ALS Therapy Institute pairs with N.J. biotech  Cambridge-based ALS Therapy Institute has teamed up with a New Jersey biotech to test several small-molecule compounds that have the potential to slow or stop the progression of Amyotrophic Lateral Sclerosis (ALS), commonly called Lou Gehrig's disease.
    Mass High Tech  March 17, 2010  


More... | Submit News Release | Advertising...

News

New Job Postings...

Free Job Posting Trial Offer
  • Director/Associate Director, Medical Information & Medical Communication Seattle Genetics, Inc. (WA)
  • Director/Associate Director of MSL Team Seattle Genetics, Inc. (WA)
  • Drug Development Associate Project Manager Seattle Genetics, Inc. (WA)
  • Corporate Communications Specialist Seattle Genetics, Inc. (WA)
  • Scientist/Senior Scientist, Formulations Seattle Genetics, Inc. (WA)
More... | Job Advertising... | About Job Postings...
Master's Degree in Biomedical Regulatory Affairs

New Facilities Available...

ATC clean room constructors...validation guaranteed!

  • 890 Embarcadero Road Property -- West Sacramento, CA
  • CompleGen Lab/Office Space -- Seattle, WA
  • Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
Facilities

Upcoming Events...

  • 03/19/2010: Setting up Phase I, II and III clinical trials with antibiotics and antiinfectives for small to medium sized companies
  • 03/19/2010: The Conference on Biosimilars
  • 03/19/2010: Online Webinar: Validating Radiation Sterilization
  • 03/22/2010: Career Paths in Healthcare IT Life Sciences Companies
  • 03/23/2010: Recruit to Retain™: Overcoming Recruitment Barriers for Clinical Studies
More... | Submit Event | Event Advertising...
Master's Degree in Biomedical Regulatory Affairs

Learn About New Jersey's BioHistory

Learn About New Jersey's BioHistory Why is there a life science industry in New Jersey? Is the industry growing? What do other states have?

Through New Jersey BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in New Jersey.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


March - National Colorectal Cancer Awareness Month

National Colorectal Cancer Awareness Month

As a leading health organization for 25 years, the Prevent Cancer Foundation, the vision of Carolyn Aldigé, has catapulted cancer prevention to prominence and provided more than $113 million in support of cancer prevention and early detection research, education and community outreach programs across the country.

More...


BioFact

(1895) - A German company, Hochst am Main, sells Nitragin, the first commercially cultured Rhizobia isolated from root nodules.


It's a Small World

  MRSA Bacteria MRSA Bacteria  

Science Quote

"The intention of the Holy Ghost is to teach us how one goes to heaven, not how heaven goes."

-  Galileo Galilei, Italian physicist and astronomer
 (1564-1642)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

NewJerseyLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of New Jersey.